Recurrent hepatitis C after liver transplantation is a universal phenomenon. Graft reinfection occurs rapidly; once it is established, allograft cirrhosis and decompensation rapidly ensue in many patients. Treatment with pegylated interferon plus ribavirin is the standard of care among nontransplant
Current research in the treatment of alcoholism in liver transplant recipients
โ Scribed by Weinrieb, R M ;O'Brien, C P
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 1997
- Tongue
- English
- Weight
- 121 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1074-3022
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
A s liver transplantation in the alcoholic patient has become more common, the outcome in these patients has become important information in grounding the ethical debate that still surrounds this charged topic. Controversy has existed since alcoholic patients began receiving organ transplants in the
To determine the safety and efficacy of ganciclovir usually experience progressive liver disease over an treatment of hepatitis B virus (HBV) infection after liver accelerated time course and pose a difficult managetransplantation, nine patients (seven males, two females; ment challenge. The treatm
Hepatitis C recurrence after liver transplantation is a serious problem, leading to increased graft loss and morbidity in some individuals. Treatment with interferon and other agents is controversial and not highly efficacious. The use of an effective antiviral agent to reduce or eliminate viral bur
Eighty-four patients with the diagnosis of end-stage alcoholic liver arate analysis of high-risk patients with poly-drug use disease underwent liver transplantation from April, 1986 to July, (n ร 15, alcohol recidivism 8/15, 53%) and the remaining 1994. A diagnosis of alcohol dependence was establis